Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2992-3005
doi: 10.1161/CIRCULATIONAHA.106.685206
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Han, M. K.
Right arrow Articles by Martinez, F. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, M. K.
Right arrow Articles by Martinez, F. J.
Related Collections
Right arrow Pulmonary circulation and disease

(Circulation. 2007;116:2992-3005.)
© 2007 American Heart Association, Inc.


Cardiovascular Involvement in General Medical Conditions

Pulmonary Diseases and the Heart

MeiLan K. Han, MD, MS; Vallerie V. McLaughlin, MD; Gerard J. Criner, MD; Fernando J. Martinez, MD, MS

From the University of Michigan Health System (M.K.H., V.M., F.J.M.), Ann Arbor, Mich, and Temple University School of Medicine (G.C.), Philadelphia, Pa.

Correspondence to Fernando J. Martinez, MD, MS, 1500 E Medical Center Dr, 3916 Taubman Center, Ann Arbor, MI. E-mail fmartine{at}umich.edu

The complex nature of interactions between the pulmonary and cardiovascular systems is becoming increasingly appreciated. Pulmonary vascular abnormalities are frequently present in patients with respiratory disorders, including chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, sarcoidosis, neuromuscular or chest wall disorders, and disorders of ventilatory control including sleep apnea syndromes and obesity hypoventilation syndrome. Pulmonary hypertension, classified as group III in the World Health Organization classification scheme for pulmonary hypertension, may result in severe right ventricular dysfunction caused by lung disease, also known as cor pulmonale. The development of cor pulmonale is generally associated with poorer prognosis and increased death. Systemic manifestations of lung disease, particularly obstructive disorders, are also particularly relevant because they are associated with increased cardiac death and impaired health status. This article will discuss the most common pulmonary diseases and disorders of ventilatory control that cause pulmonary vascular abnormalities and cor pulmonale, with particular concentration on how treatment of these diseases may affect the heart. In addition, the complex nature of cardiac and lung disease will also be explored, particularly with respect to the relationship between chronic obstructive pulmonary disease, systemic inflammation, atherosclerosis, and cardiovascular death, which is currently a very active focus of research.


Key Words: pulmonary heart disease • pulmonary disease, chronic obstructive • hypertension, pulmonary • inflammation




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Humbert
Update in Pulmonary Arterial Hypertension 2007
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 574 - 579.
[Full Text] [PDF]